Table 3: Adverse events during single-dosed esomeprazole- and pantoprazole-based triple therapies.

Adverse events EAC group (n = 208) PAC group (n = 244) P value Diarrhea 7 (3.4%) 10 (4.1%) .131 Constipation 1 (0.5%) 2 (0.8%) 1.000 Abdominal pain 3 (1.4%) 9 (3.7%) .241 Anorexia 1 (0.5%) 3 (1.2%) .633 Nausea 7 (3.4%) 8 (3.3%) 1.000 Vomiting 1 (0.5%) 4 (1.6%) .388 Skin rash 0 (0%) 5 (2%) .069 Dizziness 12 (5.8%) 11 (4.5%) .519 Headache 2 (1%) 8 (3.3%) .196 Taste perversion 32 (15.4%) 29 (11.9%) .209 Fatigue 10 (4.8%) 6 (2.5%) .198